Hepatitis B virus (HBV) Is the type member of the hepadnavlrldae, small enveloped DNA viruses that replicate through reverse transcription of an RNA Intermediate, the pregenome. This reaction occurs usually inside the viral nucleocapsld, the assembly of which requires specific Interactions between multiple copies of the core protein, the viral replication enzyme (P protein) and the RNA pregenome which also serves as mRNA for both proteins. Deletion studies have established that specific packaging of the RNA is mediated by a short c/s-acting sequence, the encapsidation signal e. Using nuclease sensitivity experiments we provide experimental evidence that part of this sequence can adopt a stem-loop structure that Is Interrupted by a bulge and a single unpaired U residue. The structural consequences of deletions of the unpaired regions and changes In their primary sequences were investigated In vitro, and their Influence on the function of the esignal was tested in animal cells by monitoring encapsidation of RNAs carrying the mutant e-sequences In front of a 2.7 kb foreign RNA fragment, or within the context of a complete HBV genome. The data indicate that the entire stem-loop structure containing the bulge and the loop Is critical for encapsidation competence. While gross alterations In the primary sequences of the unpaired regions Interfere with encapsidation, data obtained with additional mutants suggest that the bulge region Is more tolerant to sequence changes than the loop.
INTRODUCTION
Hepatitis B virus (HBV), the causative agent of B-type hepatitis in man, is the prototypic member of the hepadnaviridae, small enveloped animal viruses with narrow host range and pronounced liver tropism. Its 3.2 kb genome is organized in four, partially overlapping open reading frames (ORFs): the preC/C gene encodes the core protein, the P gene the reverse transcriptase (P protein), thepreS/S gene the outer envelope proteins, and the X gene a transcriptional transactivator protein (Fig. 1A) .
Though considered a DNA virus, HBV replicates by reverse transcription of an RNA intermediate (reviewed in ref. 1) . This essential step in the viral life-cycle takes place inside the inner capsid, or core particle. Assembly of such replication-competent cores requires the interaction of 180 subunits of the core protein, the P protein, and one of several viral transcripts, the RNA pregenome (reviewed in ref. 2) . This transcript serves also as mRNA for core and P protein.
While the primary sequence requirements for self-assembly and RNA packaging in the core protein have been mapped (3) (4) (5) , the interactions involving the P protein and the RNA pregenome are less well understood. However, recent studies have demonstrated that P protein and pregenome encapsidation are mutually dependent (6, 7) , and that the cw-acting signal mediating specific pregenome packaging (the encapsidation signal e) resides in a stretch of about 85 nt close to the RNA's 5'-end; this sequence, if fused to a foreign RNA, is sufficient to direct its encapsidation into HBV capsids if P and core protein are provided in trans (8, 9) . These data suggest that RNA packaging is triggered by direct recognition by the P protein, or a complex of P protein with one or few core protein subunits, of a binding site within the esequence.
The genetically mapped encapsidation sequence contains several inverted repeats with the potential to form a bipartite stemloop structure (8) . The predicted structural features are phylogenetically conserved between individual HBV isolates but also between HBV and related animal hepadnaviruses. In addition, we have shown that translating ribosomes halted upstream but physically extending into the predicted stem-loop structure interfere with e-function (10) .
Though very suggestive, the available evidence for the presence of this structure and its importance for RNA encapsidation is so far indirect. We therefore directly analyzed the structure of the encapsidation sequence as present on short in vitro transcribed RNAs, and compared it to that of several mutants lacking flanking or internal sequences, or carrying nt-exchanges in the predicted loop and bulge regions. To correlate the structural data with their potential functional importance, we analyzed the influence of ntexchanges within e on encapsidation competence by expressing in animal cells elacZ fusion RNAs and monitoring their packaging into HBV nucleocapsids. In addition, the influence of selected e-mutations on the formation of replication-competent core particles was tested in the context of correspondingly altered complete HBV genomes.
The data reported below strongly suggest that the e-sequence can adopt a bipartite stem-loop structure closely resembling the predicted model, and that the entire structure but also specific sequences within e are required to confer encapsidation competence to the corresponding RNAs.
MATERIALS AND METHODS Chemicals and enzymes
Oligonucleotides were synthesized by standard phosphoramidite chemistry on an Applied Biosystems 38IB synthesizer. Reagents for denaturing PAGE were obtained from Serva (Heidelberg, Germany), those for agarose gel electrophoresis from FMC (Rockland, Maine). Enzymes for molecular cloning experiments were purchased from Boehringer (Mannheim, Germany) or New England Biolabs (Bad Schwalbach, Germany) and used as recommended by the manufacturer. Nucleases A, Tl, SI and VI were from Pharmacia (Freiburg, Germany), T7 RNA polymerase from Stratagene (Heidelberg, Germany).
Bacterial strains
For all cloning experiments, E.coli DH5a cells were used. Cells were grown at 37°C in Standard I medium (Merck, Darmstadt, Germany) in the presence of 50 /tg/ml of ampicillin.
Cells and transfections
The human hepatoma cell line HuH7 was used for all transfection experiments. 20 ng of the desired plasmid DNA was introduced into the cells in a 10 cm dish by the calcium-phosphate method as previously described (4).
Plasmid constructs
The HBV numbering system used for all of the constructs described below is that of Pasek et al. (11) . The pCHG-3122 series of plasmids is derived from plasmid pCHG-3134/36 (9) and contains, under control of the human cytomegalovirus (CMV)-IE promoter, HBV sequence from nt-position 3122 to 36 with engineered sites for Cla I site (nt-position 7), Eco RI (nt-position 22) and Xba I (nt-position 34) followed by a linker, an E.coli lacZ fragment (nt 26 to 2778), and the polyadenylation signal from simian virus 40 (cf. Fig. IB) . The Cla I site of the lacZ gene (nt-position 838) present in plasmid pCHG-3134/36 was deleted by filling-in the ends and religation, creating an Nru I site. Mutants ARB and ACB were obtained by cutting plasmid pCHG-3122 with Eco RI and Bgl II, or Cla I and Bgl II respectively, filling-in the ends and religation. Mutations creating variants ApaL and ApaB were introduced via cloning of correspondingly altered synthetic restriction fragments. In vitro transcribed e-lacZ sense RNAs were obtained using a derivative of plasmid pCHG-3122 carrying a T7 promoter between the CMV promoter and the e-lacZ cassette.
The pBSe-3124 plasmids used for in vitro transcriptions were prepared by cloning the small Kpn I to Bam HI fragment from Schematic representation of the e-lacZ constructs used to analyse encapsidation competence of mutant e-sequences. In the pCHG-3122 plasmids, the CMV promoter drives transcription of an RNA containing HBV sequence from nt-position 3122 to 36, followed by a linker and a 2.75 kb fragment corresponding to the E.coli lacZgenc; termination is controlled by an SV40 polyadenylation signal. Relevant restriction sites are shown with their position using HBV nomenclature. tocZ coordinates are relative to the authentic lacZ start codon. C. Constructs for in vitro structure mapping. The Kpn I-Bam HI fragment from pCHG-3122 was transferred into pBSIISK(-); the Kpn I-Nsi I fragment was subsequently deleted to give pBSe3124. In vitro transcription from the T7 promoter yields RNAs with 11 vector-derived nt (stippled wavy line) followed by HBV sequence from nt-position 3124 which end depending on the restriction site used to linearize the plasmid. die corresponding pCHG-3122 constructs into pBSII SK(-) (Stratagene, Heidelberg, Germany) and subsequent deletion of the internal Kpn I to Nsi I (nt-position 3119) fragment (see Fig. 1Q . Transcription with T7 RNA polymerase produces RNAs with an 1 lnt vector-derived sequence followed by HBV specific sequence starting at nt-position 3124 (see Fig. 2B for the complete sequence).
emutants in the context of a complete HBV genome were obtained by transferring Pst I-Eco RI restriction fragments containing the CMV promoter plus e-sequence from the corresponding pCHG-3122 constructs into plasmid pCHT-3O91sCX (see Fig. 1A ) which is identical to the previously described plasmid pCHT-3091 (4) except that the sequence from nt position 8 to 241 is derived from a synthetic C gene (12) . Genomic RNA from the resulting pCHT-3122 plasmids starts at nt position 3122 rather than 3100 (Fig. 1A) .
The plasmids used to prepare probe RNAs for RNAse protection experiments (cf. Fig. 4A ) contain the lacZ fragment to the Hpa I site at position 1061 fused to HBV sequence from nt 3165 to 88 (probe 1) or 1409 to 1529 (probe 2) followed by the T7 promoter; the lacZ Cla I site was filled-in as described above. The sequences of all constructs were confirmed by direct plasmid sequencing using Sequenase (USB, Bad Schwalbach, Germany).
In vitro transcription of e-containing RNAs
The corresponding pBSe3124 plasmids were linearized with Bgl II, orClal (cf. Fig. 1Q , and transcripts prepared using T7 RNA polymerase according to published procedures (13).
RNA structure probing experiments
For direct structure probing, the in vitro transcribed RNAs were 5'-labeled by T4 polynucleotide kinase and ^-[^PJ-ATP (Amersham, Braunschweig, Germany) after treatment with calf intestinal phosphatase according to published procedures (14) . Labeled RNAs (approximate specific activity: 10 5 cpm/pmol) were purified by preparative gel electrophoresis (15) . Approximately 1 pmol of RNA was mixed with 10 ng of tRNA, and incubated with the desired nuclease in a total volume of 80 id in incubation buffer A (10 mM Tris/Cl-, 10 mM MgCl 2 . 50 mM KC1, pH 7.5). Conditions for individual nucleases were 0.5 U RNAse Tl/10 min at room temperature (RT); 0.5 U RNAse Vl/10 min at RT; 0.66 ng RNAse A/20 min at RT; and 50 U nuclease Sl/2 min at 37°C. Sequencing markers were generated by treatment of labeled RNA with dimethyl sulfate (DMS) as described (16) . Alkaline hydrolysis ladders were prepared by heating 1 pmol of the labeled RNAs together with 5 fig of tRNA for 5 min at 100°C at pH 9 (17) . Reaction products were separated by denaturing PAGE on gels containing 15% polyacrylamide and 7 M urea and visualized by autoradiography. For primer extensions, nuclease treatments were performed with unlabeled RNA as described above; a 5'-labeled HBV specific antisense oligonucleotide complementary to HBV nt-positions 22-48 was annealed to the reaction products and extended using AMV-reverse transcriptase as previously described (18) .
Encapsidation assay
The principal of the assay has been previously described (8, 10) . In brief, cells were lysed 3 days post transfection; from 20% of the lysate total RNA was prepared; from the remainder, core particles were isolated by immunoprecipitation using a polyclonal rabbit antiserum elicited against core particles produced in E.coli (3) . Encapsidated RNA was prepared by proteinase K treatment and phenol extraction. Both RNA fractions were incubated with in vitro transcribed antisense probe RNAs and subsequently incubated with a mixture of RNAses A and Tl. Protected probe fragments were analysed on denaturing gels containing 6% polyacrylamide and visualized by autoradiography. In some experiments, data were evaluated using a Phosphor-Imager system (Molecular Dynamics, Krefeld, Germany).
Endogenous polymerase assay
Core particles were isolated from transfected cells as described above and incubated with dNTPs; DNA produced by reverse transcription of the encapsidated RNA was isolated by treatment with proteinase K and analysed by gel electrophoresis in SDScontaining 1.2% agarose gels as previously described (19) . 
RESULTS

Structural analysis of the HBV encapsidation signal
The previous mapping of e (8, 9) showed that the HBV sequence from nt positions 3134 to 36 is sufficient for pregenome encapsidation, i.e. the 34 nt at the very 5'-end (starting at ntposition 3100) are dispensable (Fig. 1A ). For the structure probing experiments, in vitro transcripts from the pBSe3124 plasmid were used which encompass HBV nt 3124 to 36 preceded by 11 vector derived nt ( Fig. 1C and 2B ); according to a computer analysis these extra nt do not interfere with the formation of the predicted structure. A number of nt-exchanges in the 3'-flanking sequence introduce restriction sites that allow for the synthesis of 3 -truncated RNAs, and which can also be used to exchange complete or partial e-cassettes between constructs. The engineered Cla I (nt pos. 7) and Eco RI (nt-pos. 22) sites do not interfere with encapsidation competence in the context of the complete HBV genome (12) . We refer to this pseudo-wt RNA as
The structure of the ^v/X. e-sequence is in accord with computer prediction and not detectably influenced by 3'-flanking sequences In vitro transcribed RNA from the l^-wt construct linearized with Bgl II (nt-pos. 37) was 5'-labeled and subjected to digestion with ss-specific nucleases Tl, A, SI and ds-specific nuclease VI. In parallel, a 3'-truncated transcript (i/'-wtACla) was obtained by cutting the plasmid with Cla I (nt-pos. 7). The reaction products were separated on a denaturing poly aery lamide gel (Fig. 2 A) alongside a hydroxy ladder Qanes OH~) and the products obtained by chemical modification with the G-specific reagent dimethyl sulfate (lanes DMS). Two regions sensitive to the ssspecific nucleases, and four regions sensitive to nuclease VI were detected, at identical positions for the i/^wt ( Fig.2A, left) , and the truncated RNA ( Fig. 2A, right) . Using the G-specific products as markers, their positions could be assigned to the computer-predicted bulge, loop and stem structures. A number of additional bands appeared also in the untreated lanes although the RNAs had been gelpurified, indicating the occurrence of spontaneous scission products. Of these, the band marked with an asterisk in Fig. 2A was consistently observed; according to the above assignment it corresponds to the 3'-edge of the bulge at the sequence C-A. This is in accord with a previous report that showed spontaneous scission to occur preferentially at pyrimidine/A bonds in or at the border of single-stranded regions (20) . These results were confirmed when the nuclease cleavage sites were mapped by primer extension (not shown). The data are schematically summarized in Fig. 2B . We conclude that the structure of the ^-wt RNA is in accord with the computer prediction, and is not detectably influenced by 3'-flanking sequences beyond the Cla I site at nt-position 7.
Structure of variants of the encapsidation sequence
To establish whether, like in other systems (e.g. HTV-l Tat/TAR; reviewed in refs. 21, 22) , one, or both unpaired regions are important for e-function, we introduced two gross alterations by deleting the 6 nt constituting the bulge and the loop in the i/<-wt sequence and, as a first step, analysed the structural changes induced by the mutations.
According to computer prediction, removal of the 6 bulge nt (mutant Abulge, AB) should give a long uninterrupted stem-loop structure (Fig.3A) in which all basepairs present in the wt structure are preserved. By contrast, the most stable structure predicted for the mutant lacking the loop nt (Aloop, AL) differs substantially from the wt structure: while the base-pairings in the lower stem are conserved, they are completely rearranged in the upper stem-loop (Fig. 3B) . The nuclease experiments performed with RNA from mutant AB showed only one region accessible to ss-specific nucleases which mapped to the predicted loop (Fig. 3A) . This mutant therefore represents a true bulge deletion. By contrast, the data obtained for mutant AL agreed only partially with the prediction: VI-specific cuts were detected in the region of the lower stem, but also in the predicted loop. Likewise, SI and Tl specific products occurred in regions predicted to be base-paired (Fig. 3B ). This information was used A. to generate a revised computer model in which the original bulge is preserved, and which differs from the wt structure only in that the upper stem-loop structure is shortened (Fig. 3Q . Hence this mutant resembles indeed a loop deletion. The revised structure, by computer analysis, is less stable than the originally predicted one (-28.0 kcal/Mol vs. -29.2 kcal/Mol). In two additional mutants, the sequence in the bulge (CUGUUQ or in the loop (CUGUGC) was changed to GGGCCC, the recognition site for Apa I, giving the variants ApaB and ApaL. Nuclease digestion experiments (not shown) indicate that the structure of variant ApaL is essentially identical to that of the i^wt-RNA, in accord with the computer prediction. This mutant therefore represents an esignal with a loop of altered primary sequence. For mutant ApaB, the computer predicted structure retains the lower stem and the upper stem with the loop as in the wt; the bulge, however, is shifted in the 3'-direction. Nuclease digestion did not yield an unambiguous structure for this mutant. Unpaired nt were detected by nucleases SI, Tl and A at a position corresponding to the loop in the wt sequence, as predicted; however, ss-specific cuts were found both at the original position of the bulge and at the 3'-shifted position predicted for the mutant sequence. On the other hand, also VI Figure 5 . Functional consequences of deletions downstream and inside the esequence. Encapsidation competence of the constructs indicated at the top of the lanes was analyzed by an RNAse protection assay using probe 1. T, total RNA; C, RNA in core particles; Ml and M2, RNA size markers obtained by hybridizing the probe to in vitro transcribed sense RNAs corresponding to those produced in the transfected animal cells; for M2, the template plasmid was cut at the Nru I site generated by fill-in of the Cla I site (nt-pos 838 in lacZ). Numbers with arrows show the expected sizes of protected fragments in nt. The 559 nt band corresponds to undigested probe 1. A. 3'-Flanking sequences are not important for the encapsidation function ofe. The relevant portion of a gel with the protected fragments obtained with RNAs from cotransfection of e-lacZ test constructs with the HBV helper construct is shown. B and C. Deletion of the bulge or the loop sequence impairs encapsidation-competence. Encapsidation of the elacZ variants AL and AB was analyzed by RNAse protection using probe 1, either by cotransfection with the helper alone (B.) or in the presence of helper and reference construct (C). The ^-wt construct was included as a control. Note that in lanes T bands corresponding to all constructs are present, whereas in the core fractions of mutants AL and AB only die reference specific products are visible.
cuts were observed in both potential bulge regions. Possibly, the ApaB variant adopts more than one stable structure, one resembling that of the wt, the other having a shifted bulge in an otherwise preserved structural context.
Functional analysis of the encapsidation sequence
Upon transfection into suitable liver cell lines, the HBV sequence from nt-position 3134 to 36 fused to a foreign RNA was shown to direct packaging of this RNA into HBV core particles, if core and P protein are provided in trans from a cotransfected encapsidation-deficient helper construct which itself lacks part of the encapsidation signal (8) . To analyze the encapsidationcompetence of mutant e-sequences we essentially followed a previously described protocol (8): Encapsidated RNA was extracted from core particles isolated by immunoprecipitation, and detected by an RNAse protection assay with an antisense RNA that is complementary to the lacZ part but also to a short stretch of HBV sequence (Fig. 4A) . As a control, total RNA from the cell lysates (containing free plus encapsidated RNA) was subjected to the same procedure.
For.expression of the elacZ 'test RNAs' the plasmids of the pCHG-3122 series were used which carry the same e-cassettes as described above for the pBSe-3124 constructs, followed by a 2.7 kb fragment from the E.coli lacZ gene. The possible influence of HBV sequences downstream of the e-structure was tested using mutants ARB and ACB which lack HBV-specific nt 3' of positions 26 and 10, respectively. The other variants m Figure 6 . Gross alterations in the bulge and loop sequences impair encapsidation competence. Encapsidation of the elacZ variants ApaL and ApaB was assessed by RNAse protection as in Fig. 5 , but using probe 2. The gel used to separate the reaction products was analyzed using a Phosphor-Imager system. Ml to M4, RNA size markers; Ml, undigested probe 2; M2 to M4, in vitro transcribed sense RNAs hybridized to probe 2 and treated with RNAse. M2, sense RNA extending beyond the 5'-end of the probe; M3, sense RNA ending at the Nru I site (filledin former Oa I site); M4, sense RNA as for M2 but with the original Oa I site present, i.e. corresponding to the reference RNA. correspond to the above described mutants AL, AB, ApaL and ApaB.
As a positive internal control, in some experiments an encapsidation-proficient e-lacZ RNA (the 'reference' RNA) was included which is essentially identical to the test RNA but still carries the original Cla I site inside the lacZ part covered by the RNAse protection probes (see Fig. 4B ). The probes will therefore perfectly match the test RNA but form an internal mismatch with the reference RNA, producing two smaller protected fragments (226 and 206 nt) instead of one large 432 nt fragment. Probe 1 also contained a short piece of antisense HBV-RNA, complementary to nt 3165 to 88, which yields a 106 nt protected fragment with the authentic HBV sequence in the helper RNA. Since it also hybridizes to the HBV sequence of the e-cassettes present in the test and reference constructs, additional protected fragments are produced (see Fig. 4B ). This complication does not arise with probe 2 (Fig. 4A) ; it contains a stretch of HBV sequence that is present only in the helper RNA and yields a 124 nt protected fragment.
3'-flanking sequences are not required for the encapsidation function of e
The results of the encapsidation analysis for the ^-wt and the 3'-truncated variants ARB and ACB are shown in Fig. 5A . T refers to the total RNA, C to the RNA encapsidated into core particles. Probe 1 was used for detection.
While the helper specific 106 nt fragment was detected only in the T lanes (not shown), all test RNAs gave signals corresponding to the expected 432 nt fragment both in the total as well as the encapsidated RNA fractions, indicating that they are encapsidation-competent. The 476 nt (i/<-wt and ARB) and 460 nt (ACB) bands arise from hybridization of a second test RNA to the probe molecule via their partly matching HBV sequences (see Fig. 4B ). This result was corroborated in the triple transfection including the reference RNA (not shown). Hence, fusion RNAs with HBV sequence extending to nt positions 36, Figure 7 . eMutants defective for encapsidation in elacZ RNAs cannot be rescued in the context of the complete HBV pregenome. The ^wt and mutant ecassettes were transferred into constructs encoding the complete HBV genome and tested for encapsidation competence by the endogenous polymerase reaction. Reaction products were separated on a 1.2% agarose gel. The ^-wt esequence and the bulge mutants b-sell and b-sel2 mediated production of the expected 3.2 kbDNA while all of the above described mutants, and the helper construct transfected alone were negative in this assay. The arrows indicate the position of DNA size markers with their length in kbp.
• denotes a contaminating band that does not arise from reverse transcription of the HBV pregenome.
26 and 10 are encapsidated with similar efficiency, i.e. sequences downstream of the structured part of e are not essential for encapsidation.
Bulge and loop of e are important for encapsidation competence As shown above, structural features of the wt-e-sequence are partly preserved in variants AB and AL. However, in the encapsidation assay only very weak signals were obtained in the core fractions when these mutants were transfected with the helper construct, whereas both RNAs were clearly detectable in the total RNA fractions (Fig. 5B) . This result was confirmed in the triple transfection experiments (Fig. 5C ): similar amounts of test (fragments 432 and 476) and reference RNAs (fragments 206, 226 and 270) were detected in the T lanes, but a strong signal in the C lanes was only visible for the reference RNA. This experiment excludes technical problems as the cause for the negative result with the mutants, and hence demonstrates that deletion of the unpaired regions in the e-structure impairs, or at least greatly reduces the efficieny of their encapsidation.
Gross sequence alterations in the unpaired regions of e interfere with encapsidation
Gross sequence alterations interfere with encapsidation M AL h Mutant ApaL has a structure similar to that of the wt but differs in primary sequence at four positions in the loop; mutant ApaB carries four nt-exchanges in the bulge region and may be present in two conformations. Encapsidation competence of these variants was tested using probe 2. The result of a cotransfection with the reference RNA is shown in Fig. 6 . In contrast to the referencespecific bands of 206 and 226 nt, the 432 nt bands characteristic for both mutant test RNAs were drastically reduced in the core fractions. Normalized on the amounts of encapsidated vs. free reference RNA, the encapsidation efficiency of the ^-wt RNA was about 80%, while that for both mutants was below 5%. Similar values were obtained for mutants AB and AL (not shown). .9.
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The relevant part of tbe e-sequence as present in the in vitro transcripts or in transiently expressed elacZ fusion RNAs is shown; sequence present in the structured part of e is shown in upper case letters. '.9.' indicates the presence of 9 nt with the specific sequence shown in Fig. 2B . For the mutants, dashes represent nt identical to the ^-wt sequence. Hence, deletion of the bulge or loop nt, as well as extensive substitution greatly impairs or abolishes encapsidation competence.
Analysis of e-variants in the context of a complete HBV genome The esignal alone is sufficient to mediate encapsidation, however, additional sequences present only in the authentic HBV genome may contribute to RNA packaging. We therefore tested the influence of emutations in the context of the complete HBV genome using the endogenous polymerase reaction (23) . In this assay, the HBV P protein co-packaged into core particles reverse transcribes the encapsidated RNA if provided with dNTPs. If one of the dNTPs is radioactively labeled, DNA formation can sensitively be monitored by agarose gel electrophoresis of the reaction products, usually yielding relaxed circular and linear forms of the 3.2 kb HBV DNA genome. Various of the above described mutations were introduced into a derivative of the HBV expression plasmid pCHT-9/3091, and the resulting pCHT-3122 plasmids transfected into HuH7 cells. Lacking the direct repeat DR1 (nt-positions 3106 to 3116), genomic RNA from these plasmids can give rise to linear but not circular HBV DNA. As shown in Fig. 7 , positive signals were obtained for the ypwt construct and two sequence variants in the bulge region (bsell and b-sel2; see Table 1 ) which were obtained by a selection protocol allowing to find encapsidation-competent sequences within a pool of partially randomized esequences (M.Nassal and A. Rieger, unpublished data). No signals were obtained for the AB and AL mutants, confirming that both the bulge and the loop are required for efunction. Interestingly, mutant AB did not produce core protein, presumably because the long uninterrupted stem structure cannot be efficiently penetrated by ribosomes scanning for the core initiator codon (reviewed in refs. 24, 25) . However, this variant could not be rescued by cotransfection of the helper construct providing the core (and P) protein in trans, i.e. deletion of the bulge does by itself interfere with encapsidation competence. Also the ApaB and ApaL sequence variants were negative in this assay. This confirms that the physical presence of, but also the actual sequence in the ss-stranded regions of e is important for function.
DISCUSSION
Assembly of replication-competent HBV nucleocapsids involves the three principal components core protein, P protein and pregenome, as was demonstrated by genetic approaches (1, 2, 6) . A detailed understanding of this process, however, will require the biochemical characterization of the mutual interactions between these molecules. As a step towards this end, we carried out a structural analysis of the cis-acting encapsidation signal e on the HBV pregenome, and investigated the structural and funtional consequences of a number of mutations within e. Our results indicate that the HBV packaging signal forms a bipartite stem-loop structure with a 6 nt bulge, a 6 nt loop and a single unpaired U residue, and that this structural element is required and sufficient for RNA encapsidation. Sequence-specific contributions to the function of the signal are mainly due to the apical loop, while the physical presence of the bulge region appears to be much more important than its actual sequence. Our data are summarized in Table 1 ; they are corroborated by similar findings in an independent study published after completion of this manuscript (26) .
Previous indirect evidence had suggested that e acts by adopting a specific higher order structure (8) . The data presented above prove experimentally that the e-sequence has a strong tendency to form a structure whose principal features are in accord with the originally predicted model. While not covering each individual nt of e, our nuclease sensitivity data clearly demonstrate the presence of two single-stranded regions coinciding with the predicted bulge and loop. This interpretation is further supported by the occurrence of a spontaneous scission product assigned to the sequence C-A at the 3'-edge of the bulge. Scission at this position is in perfect agreement with data derived from similar events in tRNAs, the majority of which occur at the sequence Py-A in, or close to unpaired regions (20) . From these and the nuclease VI data few, if any alternative arrangements for the esequence are possible. Hence the e-sequence can adopt a specific structure whose salient features are a bipartite stem, a 6 nt bulge, a 6 nt loop and an unpaired U-residue.
The in vitro transcripts do not contain the authentic pregenomic 5'-end. However, from previous functional studies and those described above it is evident that the sequences flanking the structure at its 5'-and 3'-side are not essential for packaging: short foreign, linker-derived 5'-sequences (8) as well as HBVspecific upstream sequences (10) do not per se interfere with efunction. We also saw no structural or functional differences for an e-sequence 3'-truncated to nt-position 10. It is therefore very likely that also the authentic pregenome can adopt the structure we have found for the in vitro transcribed e-RNA. The two internal deletion variants of e we investigated maintain most of the principal structural elements found in the wt. In contrast to mutant AB, this result was not expected from computer prediction for the AL variant. Our experimental data agree with a structure closely resembling that in the wt sequence, except that the upper stem is shortened. That this structure forms despite its lower predicted stability might suggest that the wt-structure is stabilized by additional non-Watson-Crick interactions.
Our functional data strongly suggest that the ability to form the above described structure is required and sufficient to confer encapsidation competence to the RNA, since a sequence covering the structural elements but lacking specific flanking sequences can be packaged into HBV capsids. For viral reproduction, these flanking sequences are important, however, since they contain both coding information and regulatory signals. In agreement with the report of Pollack and Ganem (26), we find no significant contribution of the 3'-flanking sequences to packaging efficiency. Concerning the reported enhancing effect of 5 '-flanking sequences the data cannot be directly compared, since both our reference and the test RNAs lack the very 5'-end of the authentic pregenome. However, preliminary data obtained with constructs carrying the complete 5'-flanking sequence suggest indeed a detectable increase in encapsidation efficiency.
The internal deletions within the e-sequence showed a drastic reduction in encapsidation competence. The weak remaining signals observed in some RNAse protection experiments could also be explained by contamination with unpackaged RNA, or, in the case of the triple transfections including the reference RNA, by the failure of RNAses A and Tl to completely cut the RNA/RNA hybrid at the site of the internal mismatch. Quantitation of the RNAse protection assay shown in Fig. 6 indicated that the ^-wt elacZ RNA was packaged with essentially the same efficiency as the reference RNA. By contrast, the bands corresponding to encapsidated RNA from mutants ApaB and ApaL had intensities of lower than 5 % of that of the reference RNA; the same results were obtained for mutants AB and AL. A more accurate quantitation was not possible due to the low signal to noise ratio in that region of the gels. However, similar values were obtained for the encapsidation of the helper RNA, demonstrating a comparable discrimination against encapsidation of the e-variants with internal deletions or sequence alterations as that observed for the 5'-truncated helper RNA. The negative result in the endogenous polymerase assay for the mutants in the context of a complete HBV genome further supports that they are encapsidation-deficient. Hence we conclude that both the bulge and the loop are required for the function of the e-signal. This suggests that the entire stemrloop structure is important, otherwise one or the other variant, both preserving some features of the wt-structure, should have been packaged.
The RNA pregenomes used in the latter experiments, like the authentic HBV pregenome, contain a second copy of e in the 3'-terminal redundancy; such a 3'-located e-sequence is also present on all subgenomic HBV RNAs. Our data confirm the previous observation that the e-signal is nonfunctional at this position (8) . The molecular basis of this phenomenon is currently unclear. It might reflect an inhibitory influence of HBV-specific upstream sequences present only on the 3'-terminal e-copy, or of downstream sequences unique to the 3'-end, e.g. the poly-A tail. At least the approximately 30 additional nt on the preC-RNAs do not per se interfere with encapsidation (10) , and a computer analysis predicts the formation of the specific secondary structure described above even in the presence of some 1000 nt upstream of e, arguing for a more complex regulation mechanism.
Structural and sequence-specific contributions to e function cannot be unequivocally dissected by our limited mutational data. Both the replacement of the bulge and the loop sequences by the recognition sequence for Apa I essentially abolished encapsidation. However, using selection of encapsidationcompetent mutants from partially randomized e-sequences (M.Nassal and A.Rieger, unpublished) we were able to find variants in the bulge but not in the loop region in which two (variant b-sell) or even four nt (variant b-sel2) of the original unpaired sequence are exchanged. Similarly, Tong et al. (27) reported three HBV variants with single nt exchanges in the bulge region that were replication-competent whereas the two single nt-exchanges in the loop region tested were both replicationdeficient. Togetfier these data suggest that in particular the loop contributes in a sequence-specific way to encapsidation, whereas fewer restrictions apply to the sequence of the bulge. This conclusion is further supported by a number of different mutants analyzed by Pollack and Ganem (26) . These authors also showed that the presence of the unpaired U residue contributes significantly to the encapsidation function. Bulged nt can induce bending or kinking of RNA helices (28) , and may be essential for protein binding, as for instance the bulged A in the phage R17 operator sequence (29, 30) , or the bulged C in the iron response element (31); hence they may be involved in recognition either directly, or by making the major groove accessible to the side chains of binding proteins (32, 33) . It will therefore be interesting to study the effects of replacing the unpaired U by other residues although, according to computer prediction, nt exchanges at this position also induce structural alterations.
The currently available data do not provide a direct clue as to why the entire structure would be required for efunction. From previous genetic studies it is highly likely that RNA encapsidation and capsid assembly are initiated by direct binding of P protein to e (6). However, the entire e-sequence defined in this study appears rather large for binding of a single protein. One possibility is that only the combination of the individual secondary structure elements confers to the RNA a three-dimensional structure that can be recognized by P protein; secondly, and analogously to the HTV-1 Tat/TAR system, where a bulge is required for Tat-binding, but additional binding of (a) cellular protein(s) to the TAR loop appears to be required for function (21) , cellular factors may be involved in the encapsidation process. Alternatively, or additionally, the e structure, possibly triggered by P protein binding, might expose a specific recognition site for the core protein for which so far only a nonsequence specific affinity for nucleic acids has been demonstrated (5). This situation would again have a precedent in the HTV-1 Tat/TAR system where specific binding of Tat, mediated by recognition of the bulge region in TAR, is superimposed on a general affinity for RNA of the protein (22, 34, 35) . Experiments towards an in vitro system to dissect P protein binding from encapsidation are currently underway.
